Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucllMORABITO, Fortunato; MANGIOLA, Massimo; STELITANO, Caterina et al.Haematologica (Roma). 2002, Vol 87, Num 2, pp 217-218, issn 0390-6078Article

Clonal heterogeneity in chronic lymphocytic leukemia cells : superior response to surface IgM cross-linking in CD38, ZAP-70-positive cellsCUTRONA, Giovanna; COLOMBO, Monica; MORABITO, Fortunato et al.Haematologica (Roma). 2008, Vol 93, Num 3, pp 413-422, issn 0390-6078, 10 p.Article

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myelomaPALUMBO, Antonio; AMBROSINI, Maria Teresa; BRINGHEN, Sara et al.Blood. 2007, Vol 109, Num 7, pp 2767-2772, issn 0006-4971, 6 p.Article

Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: Experience of the Intergruppo Italiano LinfomiMORABITO, Fortunato; GALLAMINI, Andrea; VITOLO, Umberto et al.Cancer. 2004, Vol 101, Num 7, pp 1601-1608, issn 0008-543X, 8 p.Article

Efficacy and safety of once-weekly bortezomib in multiple myeloma patientsBRINGHEN, Sara; LAROCCA, Alessandra; GUGLIELMELLI, Tommasina et al.Blood. 2010, Vol 116, Num 23, pp 4745-4753, issn 0006-4971, 9 p.Article

Integrative Genomics Analyses Reveal Molecularly Distinct Subgroups of B-Cell Chronic Lymphocytic Leukemia Patients with 13q14 DeletionMOSCA, Laura; FABRIS, Sonia; GENTILE, Massimo et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5641-5653, issn 1078-0432, 13 p.Article

Proposal and Validation of Prognostic Scoring Systems for IgG and IgA Monoclonal Gammopathies of Undetermined SignificanceROSSI, Francesca; PETRUCCI, Mariateresa; MUSTO, Pellegrino et al.Clinical cancer research (Print). 2009, Vol 15, Num 13, pp 4439-4445, issn 1078-0432, 7 p.Article

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patientsMARTINO, Massimo; CONSOLE, Giuseppe; BRUGIATELLI, Maura et al.American journal of hematology. 2006, Vol 81, Num 12, pp 973-978, issn 0361-8609, 6 p.Article

B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma : role of ZAP70 determination on bone marrow biopsy specimensSABATTINI, Elena; ORDUZ, Rocio; CAMPIDELLI, Cristina et al.Journal of clinical pathology. 2007, Vol 60, Num 6, pp 627-632, issn 0021-9746, 6 p.Article

IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukaemiaBAGNARA, Davide; CALLEA, Vincenzo; FAIS, Franco et al.British journal of haematology. 2006, Vol 133, Num 1, pp 50-58, issn 0007-1048, 9 p.Article

Splenic marginal zone lymphoma : a prognostic model for clinical useARCAINI, Luca; LAZZARINO, Mario; UNGARI, Marco et al.Blood. 2006, Vol 107, Num 12, pp 4643-4649, issn 0006-4971, 7 p.Article

A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility lociSELLICK, Gabrielle S; WEBB, Emily L; LYTTELTON, Matthew et al.American journal of human genetics. 2005, Vol 77, Num 3, pp 420-429, issn 0002-9297, 10 p.Article

Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemiaMORABITO, Fortunato; MANGIOLA, Massimo; OLIVA, Bianca et al.Leukemia research. 2001, Vol 25, Num 11, pp 927-932, issn 0145-2126Article

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized TrialPALUMBO, Antonio; CAVO, Michele; NOZZOLI, Chiara et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 986-993, issn 0732-183X, 8 p.Article

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experienceLAURENTI, Luca; TARNANI, Michela; MONTANARO, Marco et al.American journal of hematology. 2011, Vol 86, Num 12, pp 1007-1012, issn 0361-8609, 6 p.Article

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemiaMORABITO, Fortunato; CUTRONA, Giovanna; SPRIANO, Mauro et al.British journal of haematology. 2009, Vol 146, Num 1, pp 44-53, issn 0007-1048, 10 p.Article

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis : the superior disease control of R-HDS does not translate into an overall survival advantageLADETTO, Marco; DE MARCO, Federica; GALLAMINI, Andrea et al.Blood. 2008, Vol 111, Num 8, pp 4004-4013, issn 0006-4971, 10 p.Article

The clinical value of tumor burden at diagnosis in Hodgkin lymphomaGOBBI, Paolo G; BROGLIA, Chiara; PAULLI, Marco et al.Cancer. 2004, Vol 101, Num 8, pp 1824-1834, issn 0008-543X, 11 p.Article

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsCORTELEZZI, Agostino; GRITTI, Giuseppe; ZALLIO, Francesco et al.British journal of haematology. 2012, Vol 156, Num 4, pp 481-489, issn 0007-1048, 9 p.Article

Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLLMORABITO, Fortunato; CUTRONA, Giovanna; VIGNA, Ernesto et al.British journal of haematology. 2010, Vol 149, Num 1, pp 160-163, issn 0007-1048, 4 p.Article

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma : updated results of a randomized controlled trial. CommentaryDURIE, Brian G. M; PALUMBO, Antonio; ZAMBELLO, Renato et al.Blood. 2008, Vol 112, Num 8, issn 0006-4971, 2998-2999, 3107-3114 [10 p.]Article

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma : randomised controlled trial. CommentaryKUMAR, Shaji; PALUMBO, Antonio; GALLI, Monica et al.Lancet (British edition). 2006, Vol 367, Num 9513, issn 0140-6736, 791-792,825-831 [9 p.]Article

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myelomaPALUMBO, Antonio; BERTOLA, Alessandra; MUSTO, Pellegrino et al.Cancer. 2005, Vol 104, Num 7, pp 1428-1433, issn 0008-543X, 6 p.Article

Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern ItalyCAPALBO, Silvana; CALLEA, Vincenzo; MUSOLINO, Caterina et al.International journal of hematology. 2004, Vol 79, Num 4, pp 354-357, issn 0925-5710, 4 p.Article

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trialPALUMBO, Antonio; BRINGHEN, Sara; CAPALDI, Antonio et al.Blood. 2004, Vol 104, Num 10, pp 3052-3057, issn 0006-4971, 6 p.Article